The Purpose Revolution: How Leaders Create Engagement and Competitive Advantage in an Age of Social Good

Version: Unabridged
Author: John Izzo , Jeff Vanderweilen
Narrator: Jeff Hoyt
Genres: Business & Economics
Publisher: Dreamscape Media
Published In: March 2018
# of Units: 5 CDs
Length: 7 hours, 55 minutes
Ratings:
Tell Your Friends:

Overview

Customers, employees, and investors are no longer satisfied with companies providing good products, good prospects, and good profits--they want them to do some social good, too. These "purpose-driven" companies do better on nearly every traditional metric: greater customer loyalty, higher retention, more innovation, and a healthier bottom line. But a nice mission statement and donations to charity won't make your company stand out. Using scores of realworld examples and practical exercises, John Izzo and Jeff Vanderwielen help leaders find a truly authentic purpose, one that is a natural fit for them and their organization. They describe concrete actions leaders can take to ensure that employees own it, customers and recruits connect with it, and every corporate action and activity reflects it.

Author Details

Author Details

Izzo, John

John Izzo is one of North America's most prominent voices on finding more purpose in life and work. His website is http://www.drjohnizzo.com . John is a regular contributor to CSRWire.com .

John has devoted the past 25 years of his life and career to facilitating deeper conversations about values, work, life, leadership and success. He has worked with thousands of leaders, professionals and front-line colleagues to foster workplaces of excellence, purpose, learning and renewal. His clients have ranged from high tech to high touch, hotels to hospitals, and from government agencies to entrep

Vanderweilen, Jeff

Jeff Vanderwielen is vice president of consulting at Izzo Associates and a former senior change consultant at Ernst & Young. He has consulted to many of the world's leading companies, including Chevron, Catholic Healthcare West, Trinity Health System, Merck, Northrop Grumman, UBS, Conagra Brands, and Amgen.